Marshall Wace North America’s Dermira, Inc. DERM Stock Holding History

Marshall Wace North America’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-19,308	Closed	-$123K	–	1754
2019 Q3	$123K	Buy	+19,308	New	+$161K	﹤0.01%	1024
2018 Q4	–	Sell	-11,743	Closed	-$128K	–	1734
2018 Q3	$128K	Buy	+11,743	New	+$118K	﹤0.01%	862
2018 Q2	–	Sell	-445,280	Closed	-$3.56M	–	1871
2018 Q1	$3.56M	Sell	445,280 -209,816	-32%	-$4.57M	0.02%	648
2017 Q4	$18.2M	Buy	655,096 +379,962	+138%	+$10.1M	0.1%	248
2017 Q3	$7.43M	Sell	275,134 -380,201	-58%	-$9.95M	0.05%	440
2017 Q2	$19M	Buy	655,335 +58,394	+10%	+$1.77M	0.14%	189
2017 Q1	$20.3M	Buy	+596,941	New	+$19.3M	0.16%	176

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace North America's DERM Position: Q4 2019 in Review

Marshall Wace North America sold out of Dermira, Inc. (DERM) in Q4 2019, closing a stake of 19,308 shares — an estimated $123K sold.

Marshall Wace North America first reported a position in DERM in Q1 2017 and held it in 7 quarters. The position peaked at $20.3M in Q1 2017. 133 funds tracked by Wall St. Rank hold DERM as of Q4 2019.

Marshall Wace North America reported no remaining Dermira, Inc. position as of Q4 2019 after selling out during the quarter.
Marshall Wace North America sold 19,308 Dermira, Inc. shares in Q4 2019, an estimated $123K.
Marshall Wace North America first reported a position in Dermira, Inc. in Q1 2017 and held it in 7 quarters.
Marshall Wace North America's Dermira, Inc. position peaked at $20.3M in Q1 2017.
133 funds tracked by Wall St. Rank held Dermira, Inc. as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.